Cargando…

Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects

Dietary supplements containing L-arginine have been marketed with the purpose of increasing vasodilatation, and thus, blood and oxygen supply to the exercising muscle. The present study evaluated the acute effect of L-arginine supplementation on indicators of NO production, nitrite (NO(2)(-)) + nitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvares, Thiago Silveira, Conte-Junior, Carlos Adam, Silva, Joab Trajano, Paschoalin, Vânia Margaret Flosi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489573/
https://www.ncbi.nlm.nih.gov/pubmed/22691607
http://dx.doi.org/10.1186/1743-7075-9-54
_version_ 1782248744168718336
author Alvares, Thiago Silveira
Conte-Junior, Carlos Adam
Silva, Joab Trajano
Paschoalin, Vânia Margaret Flosi
author_facet Alvares, Thiago Silveira
Conte-Junior, Carlos Adam
Silva, Joab Trajano
Paschoalin, Vânia Margaret Flosi
author_sort Alvares, Thiago Silveira
collection PubMed
description Dietary supplements containing L-arginine have been marketed with the purpose of increasing vasodilatation, and thus, blood and oxygen supply to the exercising muscle. The present study evaluated the acute effect of L-arginine supplementation on indicators of NO production, nitrite (NO(2)(-)) + nitrate (NO(3)(-)) (NOx), in healthy subjects. Plasma concentrations of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) have also been addressed. Seventeen healthy males participated in a randomized, double-blind, placebo-controlled study. Blood samples were drawn from a left antecubital vein at baseline (T0). Afterwards, subjects were randomly submittedto 6 g of oral L-arginine supplementation (as L-arginine hydrochloride) or placebo (as corn starch); afterwards, the subjects remained at rest in supine position and blood samples were drawn again at 30 (T1), 60 (T2), 90 (T3) and 120 minutes (T4) after supplementation. To analyze NO production, NO(3)(-) was converted to NO(2)(-) by nitrate reductase, followed by the derivatization of NO(2)(-) with 2,3-diaminonaphthalene. NOx, ADMA and SDMA were analyzed using a high-performance liquid chromatography system and monitored with a fluorescence detector. Two-way ANOVA with repeated measures showed no significant changes in NOx concentrations on the L-arginine group as compared to placebo group at any of the fivetime points (T0: 17.6 ± 3.9 vs 14.6 ± 2.3 μmol/L; T1: 15.8 ± 2.4 vs 14.3 ± 1.7 μmol/L; T2: 16.8 ± 4.9 vs 13.7 ± 2.7 μmol/L; T3: 16.7 ± 3.9 vs 14.6 ± 2.1 μmol/L; T4: 15.1 ± 2.8 vs 13.5 ± 3.5 μmol/L). Furthermore, plasma levels of ADMA and SDMA were not statistically significant between the L-arginine and placebo groups at T0 (0.43 ± 0.19 vs 0.39 ± 0.15 μmol/L and 1.83 ± 1.13 vs 1.70 ± 0.62 μmol/L), respectively. In conclusion, acute L-arginine supplementation does not increase plasma concentration of NOx in healthy individuals with normal plasma concentrations of ADMA.
format Online
Article
Text
id pubmed-3489573
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34895732012-11-06 Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects Alvares, Thiago Silveira Conte-Junior, Carlos Adam Silva, Joab Trajano Paschoalin, Vânia Margaret Flosi Nutr Metab (Lond) Research Dietary supplements containing L-arginine have been marketed with the purpose of increasing vasodilatation, and thus, blood and oxygen supply to the exercising muscle. The present study evaluated the acute effect of L-arginine supplementation on indicators of NO production, nitrite (NO(2)(-)) + nitrate (NO(3)(-)) (NOx), in healthy subjects. Plasma concentrations of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) have also been addressed. Seventeen healthy males participated in a randomized, double-blind, placebo-controlled study. Blood samples were drawn from a left antecubital vein at baseline (T0). Afterwards, subjects were randomly submittedto 6 g of oral L-arginine supplementation (as L-arginine hydrochloride) or placebo (as corn starch); afterwards, the subjects remained at rest in supine position and blood samples were drawn again at 30 (T1), 60 (T2), 90 (T3) and 120 minutes (T4) after supplementation. To analyze NO production, NO(3)(-) was converted to NO(2)(-) by nitrate reductase, followed by the derivatization of NO(2)(-) with 2,3-diaminonaphthalene. NOx, ADMA and SDMA were analyzed using a high-performance liquid chromatography system and monitored with a fluorescence detector. Two-way ANOVA with repeated measures showed no significant changes in NOx concentrations on the L-arginine group as compared to placebo group at any of the fivetime points (T0: 17.6 ± 3.9 vs 14.6 ± 2.3 μmol/L; T1: 15.8 ± 2.4 vs 14.3 ± 1.7 μmol/L; T2: 16.8 ± 4.9 vs 13.7 ± 2.7 μmol/L; T3: 16.7 ± 3.9 vs 14.6 ± 2.1 μmol/L; T4: 15.1 ± 2.8 vs 13.5 ± 3.5 μmol/L). Furthermore, plasma levels of ADMA and SDMA were not statistically significant between the L-arginine and placebo groups at T0 (0.43 ± 0.19 vs 0.39 ± 0.15 μmol/L and 1.83 ± 1.13 vs 1.70 ± 0.62 μmol/L), respectively. In conclusion, acute L-arginine supplementation does not increase plasma concentration of NOx in healthy individuals with normal plasma concentrations of ADMA. BioMed Central 2012-06-12 /pmc/articles/PMC3489573/ /pubmed/22691607 http://dx.doi.org/10.1186/1743-7075-9-54 Text en Copyright ©2012 Alvares et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Alvares, Thiago Silveira
Conte-Junior, Carlos Adam
Silva, Joab Trajano
Paschoalin, Vânia Margaret Flosi
Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
title Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
title_full Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
title_fullStr Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
title_full_unstemmed Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
title_short Acute L-Arginine supplementation does not increase nitric oxide production in healthy subjects
title_sort acute l-arginine supplementation does not increase nitric oxide production in healthy subjects
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489573/
https://www.ncbi.nlm.nih.gov/pubmed/22691607
http://dx.doi.org/10.1186/1743-7075-9-54
work_keys_str_mv AT alvaresthiagosilveira acutelargininesupplementationdoesnotincreasenitricoxideproductioninhealthysubjects
AT contejuniorcarlosadam acutelargininesupplementationdoesnotincreasenitricoxideproductioninhealthysubjects
AT silvajoabtrajano acutelargininesupplementationdoesnotincreasenitricoxideproductioninhealthysubjects
AT paschoalinvaniamargaretflosi acutelargininesupplementationdoesnotincreasenitricoxideproductioninhealthysubjects